Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-27
Closed -$1.45K 501
2023
Q1
$1.45K Buy
27
+1
+4% +$58 ﹤0.01% 1044
2022
Q4
$1.39K Buy
26
+13
+100% +$671 ﹤0.01% 1050
2022
Q3
$1K Sell
13
-6
-32% -$325 ﹤0.01% 1080
2022
Q2
$1K Buy
19
+5
+36% +$322 ﹤0.01% 1065
2022
Q1
$1K Buy
14
+1
+8% +$71 ﹤0.01% 664
2021
Q4
$1K Buy
+13
New +$1.09K ﹤0.01% 614

Other funds holding ENOV

Schubert & Co's ENOV Position: Q2 2023 in Review

Schubert & Co sold out of Enovis (ENOV) in Q2 2023, closing a stake of 27 shares — an estimated $1.45K sold.

Schubert & Co first reported a position in ENOV in Q4 2021 and held it in 6 quarters. The position peaked at $1.45K in Q1 2023. 261 funds tracked by Wall St. Rank hold ENOV as of Q2 2023.

  • Schubert & Co reported no remaining Enovis position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 27 Enovis shares in Q2 2023, an estimated $1.45K.
  • Schubert & Co first reported a position in Enovis in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Enovis position peaked at $1.45K in Q1 2023.
  • 261 funds tracked by Wall St. Rank held Enovis as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.